Search
01/10/2024
CLINICAL EXPERIENCE IN THE USE OF MESENCHYMAL STROMAL CELLS IN PEDIATRIC GRAFT-VERSUS-HOST DISEASE: ON BEHALF OF THE SPANISH GROUP OF STEM CELL TRANSPLANTATION (GETH)
Parente, CE, S nchez, DB, Angulo, BM, Carabante, MIB, Torija, IL, Trabazo, M, Fuentes, C, Plaza, M, Mart nez, AP, Urtasun, A, Riesco, S, Mu z, SG, Vinagre, S, de Heredia, CD, Marsal, J, Gonz lez-Vicent, M, P rez-Mart nez, A. CLINICAL EXPERIENCE IN THE USE OF MESENCHYMAL STROMAL CELLS IN PEDIATRIC GRAFT-VERSUS-HOST DISEASE: ON BEHALF OF THE SPANISH GROUP OF STEM CELL TRANSPLANTATION (GETH). BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).
01/10/2024
UNRELATED DONOR TRANSPLANTATION OFFERS A REAL CURATIVE OPPORTUNITY FOR PATIENTS WITH TRANSFUSIONDEPENDENT THALASSAEMIA. EXPERIENCE OF THE SPANISH GROUP FOR BONE MARROW TRANSPLANTATION IN CHILDREN (GETH-TC)
Carabante, MIB, Men rguez, A, Bieler, CB, Garc a, LA, Oficialdegui, MLU, Panesso, M, Fornieles, MP, Fuentes, C, Enr quez, SV, Silva, GG, Duarte, ML, Hurtado, JMP, Torrent, M, Rubio, CDD. UNRELATED DONOR TRANSPLANTATION OFFERS A REAL CURATIVE OPPORTUNITY FOR PATIENTS WITH TRANSFUSIONDEPENDENT THALASSAEMIA. EXPERIENCE OF THE SPANISH GROUP FOR BONE MARROW TRANSPLANTATION IN CHILDREN (GETH-TC). BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).
01/10/2024
USE OF LETERMOVIR IN PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS UNDER AGE OF 12: A RETROSPECTIVE MULTI-CENTRE STUDY ON BEHALF OF THE IEWP AND PDWP
Kleinschmidt, K, Lucchini, G, Galimard, JE, Balduzzi, A, Czyzewski, K, Fraczkiewicz, J, Tambaro, FP, Adamcakova, J, Urtasun, A, Woelfl, M, Bernardo, ME, Biffi, A, Kriv n, G, Torija, IL, Sedlacek, P, Holter, W, Diesch, T, Albert, MH, Sobkowiak-Sobierajska, A, Vicent, MG, Ince, E, Johnson, SM, Meisel, R, Dalissier, A, Corbacioglu, S, Neven, B, Kalwak, K. USE OF LETERMOVIR IN PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS UNDER AGE OF 12: A RETROSPECTIVE MULTI-CENTRE STUDY ON BEHALF OF THE IEWP AND PDWP. BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).
01/08/2024
Update of the Spanish clinical practice guideline for urinary tract infection in infants and children. Summary of recommendations for diagnosis, treatment and follow-up.
González Rodríguez JD, Fraga Rodríguez GM, García Vera CJ, Gómez Fraile A, Martín Sánchez JI, Mengual Gil JM, Ochoa Sangrador C, Valenciano Fuentes B, Escribano Subías J. Update of the Spanish clinical practice guideline for urinary tract infection in infants and children. Summary of recommendations for diagnosis, treatment and follow-up.. Anales De Pediatria. 2024; 101(2)DOI:10.1016/j.anpede.2024.07.010. PMID:39098586. IF:(Q/D).
01/07/2024
Defibrillation during delivery room resuscitation and the role of electrocardiographic monitoring in improving outcomes
Esmel-Vilomara, R, Armendariz-Lacasa, L, Moliner, E. Defibrillation during delivery room resuscitation and the role of electrocardiographic monitoring in improving outcomes. Pediatrics and Neonatology. 2024; 65(4)DOI:10.1016/j.pedneo.2024.04.007. PMID:38789294. IF:2.100(Q2/4D).
01/06/2024
A Mild Presentation of X-Linked Hypophosphatemia Caused by a Non-Canonical Splice Site Variant in the PHEX Gene
Fraga, G, Herreros, MA, Pybus, M, Aza-Carmona, M, Pilco-Teran, M, Furlano, M, García-Borau, MJ, Torra, R, Ars, E. A Mild Presentation of X-Linked Hypophosphatemia Caused by a Non-Canonical Splice Site Variant in the PHEX Gene. Genes. 2024; 15(6)DOI:10.3390/genes15060679. PMID:38927615. IF:2.800(Q2/5D).
01/06/2024
Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)
Carabante, MIB, Bueno, D, García, LA, Torija, IL, Marsal, J, Navarro, JMF, Oficialdegui, MLU, Panesso, M, Molina, B, Bieler, CB, Palomo, P, Martinez, AP, Diaz-de-Heredia, C. Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC). Transplantation And Cellular Therapy. 2024; 30(6)DOI:10.1016/j.jtct.2024.03.019. PMID:38521410. IF:4.400(Q1/1D).
01/06/2024
Predictive gene signature for trabectedin efficacy in advanced soft-tissue sarcoma: A Spanish group for research in sarcoma (GEIS) study
Moura, DS, Varela, JAC, Alvarez, R, Pujol, CA, Izquierdo, F, Ramos, R, Ortega, L, Martin-Davila, F, Leon, NH, Romagosa, C, Vaz-Salgado, MA, Lavernia, J, Bague, S, Mayodormo-Aranda, E, Mondaza-Hernandez, JL, Renshaw-Calderon, M, Hindi, N, Morales, CV, Martínez-Trufero, J, Broto, JM. Predictive gene signature for trabectedin efficacy in advanced soft-tissue sarcoma: A Spanish group for research in sarcoma (GEIS) study. JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(16)DOI:. PMID:. IF:41.900(Q1/1D).